| Clinical presentation, risk factors, and outcomes of immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T cell therapy: a systematic review SJ Grant, AA Grimshaw, J Silberstein, D Murdaugh, TM Wildes, AE Rosko, ... Transplantation and cellular therapy 28 (6), 294-302, 2022 | 63 | 2022 |
| What is multiple myeloma? J Silberstein, S Tuchman, SJ Grant Jama 327 (5), 497-497, 2022 | 56 | 2022 |
| Chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma: moving into the future SA Holstein, SJ Grant, TM Wildes Journal of Clinical Oncology 41 (27), 4416-4429, 2023 | 42 | 2023 |
| Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses PA Ford, SJ Grant, R Mick, G Keck Journal of Clinical Oncology 33 (15), 1674-1679, 2015 | 36 | 2015 |
| The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review H Mian, A McCurdy, S Giri, S Grant, B Rochwerg, E Winks, AE Rosko, ... Blood cancer journal 13 (1), 6, 2023 | 34 | 2023 |
| Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma H Mian, SJ Grant, M Engelhardt, C Pawlyn, S Bringhen, S Zweegman, ... Journal of geriatric oncology 11 (5), 764-768, 2020 | 32 | 2020 |
| Simplified frailty assessment tools: are we really capturing frailty or something else? S Giri, G Williams, A Rosko, SJ Grant, HS Mian, S Tuchman, S Zweegman, ... Leukemia 34 (7), 1967-1969, 2020 | 23 | 2020 |
| Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status CE Jensen, SN Vohra, KA Nyrop, AM Deal, HB Muss, EI Lichtman, ... Journal of geriatric oncology 13 (2), 182-189, 2022 | 18 | 2022 |
| Global disparities in patients with multiple myeloma: a rapid evidence assessment MV Mateos, S Ailawadhi, LJ Costa, SJ Grant, L Kumar, M Mohty, D Aydin, ... Blood cancer journal 13 (1), 109, 2023 | 16 | 2023 |
| Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper SJ Grant, HS Mian, S Giri, M Boutin, L Dottorini, NR Neuendorff, ... Journal of geriatric oncology 12 (4), 499-507, 2021 | 16 | 2021 |
| Use of geriatric assessment in cancer clinical trials: A systematic review W Lee, SJ Cheng, SJ Grant, ZA Marcum, B Devine Journal of geriatric oncology 13 (7), 907-913, 2022 | 15 | 2022 |
| Opportunities, challenges, and future directions for simulation modeling the effects of structural racism on cancer mortality in the United States: a scoping review J Jayasekera, S El Kefi, JR Fernandez, KM Wojcik, JMP Woo, A Ezeani, ... JNCI Monographs 2023 (62), 231-245, 2023 | 10 | 2023 |
| Treatment of older adult or frail patients with multiple myeloma SJ Grant, CL Freeman, AE Rosko Hematology 2021 (1), 46-54, 2021 | 9 | 2021 |
| Longitudinal analysis of patient-reported cognitive function in multiple myeloma ARS Yusuf, HM Heiling, AM Deal, CE Jensen, NJ Mangieri, KA Nyrop, ... Clinical Lymphoma Myeloma and Leukemia 22 (12), 920-927, 2022 | 8 | 2022 |
| Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system SJ Grant, S Kothari, PA Gimotty, NS Gooneratne, A Cuker Journal of Thrombosis and Thrombolysis 46, 1-6, 2018 | 8 | 2018 |
| A real‐world data analysis of predictors of early mortality after a diagnosis of multiple myeloma SJ Grant, TM Wildes, AE Rosko, J Silberstein, S Giri Cancer 129 (13), 2023-2034, 2023 | 7 | 2023 |
| Cross-sectional analysis of clinical trial availability and north carolina neighborhood social vulnerability SJ Grant, M Jansen, TM Kuo, SM Rubinstein, TM Wildes, SA Tuchman, ... JCO Oncology Practice 19 (2), e248-e262, 2023 | 7 | 2023 |
| Physical function, psychosocial status, and symptom burden among adults with plasma cell disorders and associations with quality of life CE Jensen, SN Vohra, KA Nyrop, AM Deal, MR LeBlanc, SJ Grant, ... The Oncologist 27 (8), 694-702, 2022 | 7 | 2022 |
| A CAM do Approach: the attitudes, use and disclosure of the use of complementary and alternative medicine (CAM) in those with myeloma T King, S Grant, S Taylor, K Houteas, C Barnett, K White Clinical Lymphoma Myeloma and Leukemia 15, e317-e318, 2015 | 7 | 2015 |
| Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma. S Grant, S Meykler, D Beach The Journal of community and supportive oncology 12 (11), 415-417, 2014 | 7 | 2014 |
